networks

Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma
Background: Medulloblastoma (MB) is the most common malignant paediatric brain tumour and a leading cause of cancer-related mortality …
Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma